Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV)

BACKGROUND: Tapentadol is a molecule incorporating mu opioid receptor agonism and norepinephrine reuptake inhibition to provide analgesia, with the potential for a lower incidence of gastrointestinal side effects than full mu opioid agonists. Postmarketing surveillance of tapentadol as an active pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Vosburg, Suzanne K, Beaumont, Jared, Dailey-Govoni, S Taryn, Butler, Stephen F, Green, Jody L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
PAIN & SUBSTANCE USE DISORDERS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553020/
https://www.ncbi.nlm.nih.gov/pubmed/31617931
http://dx.doi.org/10.1093/pm/pnz250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553020/
https://www.ncbi.nlm.nih.gov/pubmed/31617931
http://dx.doi.org/10.1093/pm/pnz250

Ejemplares similares